Position in LLY
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$2,481,620
+$631,044 QoQ
Shares Held
2,069
+2.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.02%
of 13F equity value
Holder Rank
#2,304
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 65%
Shared 0%
None 35%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Enterprise Financial Services Corp holds $12,653,618 across 10 Drug Manufacturers - General names. LLY ranks #2 (19.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
13,105 | $3,297,741 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
2,069 | $2,481,620 | |
| 3 | MRK |
Merck & Co., Inc.
|
18,619 | $2,392,541 | |
| 4 | JNJ |
Johnson & Johnson
|
8,275 | $2,101,601 | |
| 5 | PFE |
Pfizer Inc
|
24,377 | $586,998 | |
| 6 | AMGN |
Amgen Inc
|
1,281 | $463,875 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
7,683 | $442,694 | |
| 8 | NVS |
Novartis AG
|
2,081 | $326,133 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,481,620 | 2,069 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $1,850,576 | 2,012 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $2,137,537 | 1,989 | Shares | Defined | 2026-01-14 | |
| 2025-09-30 | $1,433,677 | 1,879 | Shares | Defined | 2025-10-15 | |
| 2025-06-30 | $1,485,783 | 1,906 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,504,807 | 1,822 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $1,389,600 | 1,800 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $1,551,280 | 1,751 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,609,765 | 1,778 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,390,992 | 1,788 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,095,305 | 1,879 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $987,244 | 1,838 | Shares | Defined | 2023-10-31 | |
| 2023-06-30 | $869,019 | 1,853 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $632,236 | 1,841 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $691,437 | 1,890 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $597,227 | 1,847 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $593,989 | 1,832 | Shares | Defined | 2022-08-09 | |
| 2022-03-31 | $521,193 | 1,820 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $480,899 | 1,741 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $394,633 | 1,708 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $360,346 | 1,570 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $311,988 | 1,670 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $257,986 | 1,528 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $371,973 | 2,513 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $414,061 | 2,522 | Shares | Defined | 2020-08-04 | |
| 2020-03-31 | $341,389 | 2,461 | Shares | Other | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||